Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015894 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-03 | 2022-03-01 | PHIO | Kontulis Caitlin | Sec, VP Fin, Admin | F - Tax | $0.82 | -4,011 | 103.8K | -4% | -$3,289 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2022-03-01 | F | D | 4,011 | $0.82 | 103,815 | D | — | — | (F2) Includes shares of common stock underlying unvested restricted stock units. |